Francis Duhay Sells Shares of enVVeno Medical Corporation $NVNO
Key Points
- Francis Duhay sold 140 shares of enVVeno Medical Corporation ($NVNO) worth $1,443.40.
- $NVNO last traded around $10.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Francis Duhay, insider at enVVeno Medical Corporation ($NVNO), sold 140 shares at an average price of $10.31, for a total transaction of $1,443.40. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
enVVeno Medical Corporation Stock Down 6.5%
Shares of enVVeno Medical Corporation ($NVNO) traded around $10 on Saturday, down 6.5% for the day.
enVVeno Medical Corporation Earnings
Analysts Set New Price Targets
About enVVeno Medical Corporation
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Get enVVeno Medical Corporation alerts
New 13F filings, insider trades, and analyst moves on $NVNO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.